N-able (NABL) Insider Notice: 31,728 Shares to Be Sold on 08/19/2025
Rhea-AI Filing Summary
N-able, Inc. (NABL) Form 144 reports a proposed sale of 31,728 common shares through Morgan Stanley Smith Barney LLC on 08/19/2025 with an aggregate market value of $245,013.13. The filing lists 187,096,094 shares outstanding. The shares to be sold were acquired from the issuer as restricted stock and performance shares: 4,588 restricted shares on 11/15/2024, 4,588 restricted shares on 08/15/2024, and 22,552 performance shares on 02/15/2025. The filer reports no securities sold in the past three months. The notice includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.
Positive
- Planned sale fully disclosed: Specifies broker, exact share count (31,728), planned sale date (08/19/2025), and aggregate market value ($245,013.13).
- Acquisition transparency: Lists acquisition dates and types: 4,588 restricted shares on 11/15/2024, 4,588 restricted shares on 08/15/2024, and 22,552 performance shares on 02/15/2025.
- No recent sales: The filer reports nothing to report for securities sold during the past three months.
Negative
- None.
Insights
TL;DR Routine insider notice: a scheduled sale of 31,728 shares totaling $245k, disclosed under Rule 144.
This Form 144 is a standard regulatory notice reporting an insider's intent to sell restricted and performance-based common shares acquired from the issuer. It specifies broker, planned sale date, number of shares, and aggregate market value. The filing also confirms no sale activity in the prior three months and includes the seller's representation regarding absence of undisclosed material adverse information. Because the form is procedural, it does not provide operational or financial performance data.
TL;DR A compliance disclosure documenting an insider sale plan; all acquisition and sale details are provided.
The document fulfils Rule 144 disclosure requirements by listing acquisition dates and types (restricted stock and performance shares), the broker handling the sale, and aggregate value. It also includes the statutory attestation about material adverse information and notes no recent sales. The filing is informational and procedural rather than a corporate governance action like a policy change or executive departure.